FOLH1 and neoplasm: We additionally estimated the tumor burden and PSMA expression by collecting 68Ga-PSMA ligand PET-derived quantitative parameters to disentangle whether deviant detection rates between groups is related to a higher visibility of tumor lesions or a different disease stage.